Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis
Abstract Introduction In pooled LIBERTY-PN PRIME/PRIME2 trials on prurigo nodularis (PN), at week 24, the stringent composite endpoint of a ≥ 4-point reduction from baseline in Worst Itch Numeric Rating Scale (WI-NRS) score combined with an Investigator’s Global Assessment for PN-Stage (IGA PN-S) sc...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare
2026-05-01
|
| Seri Bilgileri: | Dermatology and Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s13555-026-01777-z |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|